Trial
NCT03303950
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
—
Condition
Anemia
Intervention
Busulfan
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-05